US Retinal Specialists Highlight the Greatest Opportunity for Gene Therapies
March 19, 2024 14:20 ET
|
Spherix Global Insights
EXTON, PA, March 19, 2024 (GLOBE NEWSWIRE) -- Gene therapies have emerged as a ray of hope, particularly in the realm of eye diseases. The focus on the eye has provided researchers with a promising...
Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
February 19, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Parkinson’s Disease Patient Identification and Education Will Need to Improve When New Disease Modifying Therapies Are Approved, According to Spherix Global Insights
February 16, 2024 10:40 ET
|
Spherix Global Insights
EXTON, PA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Millions of people worldwide are affected by Parkinson’s disease (PD), prompting the need for effective disease-modifying therapies (DMTs) to target this...
Gene Switch/Molecular Switch Market projected to reach USD 1.4 Billion by 2030, growing at a CAGR of 11.3% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study
February 15, 2024 08:00 ET
|
PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED
Richmond, Feb. 15, 2024 (GLOBE NEWSWIRE) -- According to a research report "Gene Switch/Molecular Switch Market”, by Product Type (CAR-T Cell Therapies, Gene Therapies, Others), Payment model...
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
June 01, 2023 05:09 ET
|
Rentschler Biopharma SE
Rentschler Biopharma to conduct adeno-associated virus (AAV) process development work for manufacturing scale-up at their ATMP site in Stevenage, UKIkarovec is developing novel gene therapies to treat...
Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
March 19, 2023 19:00 ET
|
Novartis Pharma AG
Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up to 7.5 years post one-time intravenous infusionAll children (100%) in the presymptomatic intravenous...
Regenerative Medicine Market is Expected to Reach $40.6 Billion | MarketsandMarkets.
February 24, 2023 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Regenerative medicine is an emerging field of medicine that is focused on using the body’s natural healing processes to repair and regenerate damaged...
The CAR-T cell therapy market is projected to grow at an annualized rate of 23%, claims Roots Analysis
February 15, 2023 10:00 ET
|
Roots Analysis
London, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Global CAR-T Cell Therapy Market (4th Edition), 2022-2035 ” report to its list of offerings. CAR-T cell...
nChain Partners With ATMPS Ltd. to Power Their World-Leading Cell and Gene Therapy Platform Hataali
December 06, 2022 07:46 ET
|
nChain (957856)
ZUG, Switzerland, Dec. 06, 2022 (GLOBE NEWSWIRE) -- nChain, one of the largest global blockchain solutions companies, today announces its partnership with Hataali, the world-leading cell and gene...
The NAMPT inhibitors market is projected to grow at an annualized rate of 15.08% during the period 2029-2040, claims Roots Analysis
November 03, 2022 15:00 ET
|
Roots Analysis
London, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “NAMPT Inhibitors Market, 2022-2040” report to its list of offerings Cancer is one of the leading causes of...